Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay : a prospective study

Simple item page
dc.contributor.authorLawn, Stephen D.en_ZA
dc.contributor.authorBrooks, Sophie V.en_ZA
dc.contributor.authorKranzer, Katharinaen_ZA
dc.contributor.authorNicol, Mark P.en_ZA
dc.contributor.authorWhitelaw, Andrewen_ZA
dc.contributor.authorVogt, Monicaen_ZA
dc.contributor.authorBekker, Linda-Gailen_ZA
dc.contributor.authorWood, Robinen_ZA
dc.date.accessioned2011-10-13T16:59:23Z
dc.date.available2011-10-13T16:59:23Z
dc.date.issued2011-07-26
dc.descriptionCITATION: Lawn, S. D. et al. 2011. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay : a prospective study. PLoS Medicine, 8(7): e1001067, doi:10.1371/journal.pmed.1001067.
dc.descriptionThe original publication is available at http://journals.plos.org/plosmedicine
dc.description.abstractBackground: The World Health Organization has endorsed the Xpert MTB/RIF assay for investigation of patients suspected of having tuberculosis (TB). However, its utility for routine TB screening and detection of rifampicin resistance among HIV-infected patients with advanced immunodeficiency enrolling in antiretroviral therapy (ART) services is unknown. Methods and Findings: Consecutive adult HIV-infected patients with no current TB diagnosis enrolling in an ART clinic in a South African township were recruited regardless of symptoms. They were clinically characterised and invited to provide two sputum samples at a single visit. The accuracy of the Xpert MTB/RIF assay for diagnosing TB and drug resistance was assessed in comparison with other tests, including fluorescence smear microscopy and automated liquid culture (gold standard) and drug susceptibility testing. Of 515 patients enrolled, 468 patients (median CD4 cell count, 171 cells/μl; interquartile range, 102-236) produced at least one sputum sample, yielding complete sets of results from 839 samples. Mycobacterium tuberculosis was cultured from 81 patients (TB prevalence, 17.3%). The overall sensitivity of the Xpert MTB/RIF assay for culture-positive TB was 73.3% (specificity, 99.2%) compared to 28.0% (specificity, 100%) using smear microscopy. All smear-positive, culture-positive disease was detected by Xpert MTB/RIF from a single sample (sensitivity, 100%), whereas the sensitivity for smear-negative, culture-positive TB was 43.4% from one sputum sample and 62.3% from two samples. Xpert correctly identified rifampicin resistance in all four cases of multidrug-resistant TB but incorrectly identified resistance in three other patients whose disease was confirmed to be drug sensitive by gene sequencing (specificity, 94.1%; positive predictive value, 57%). Conclusions: In this population of individuals at high risk of TB, intensive screening using the Xpert MTB/RIF assay increased case detection by 45% compared with smear microscopy, strongly supporting replacement of microscopy for this indication. However, despite the ability of the assay to rapidly detect rifampicin-resistant disease, the specificity for drug-resistant TB was sub-optimal. © 2011 Lawn et al.
dc.description.urihttp://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001067
dc.description.versionPublisher's version
dc.format.extent11 pages
dc.identifier.citationLawn, S. D. et al. 2011. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay : a prospective study. PLoS Medicine, 8(7): e1001067, doi:10.1371/journal.pmed.1001067.
dc.identifier.issn1549-1277 (online)
dc.identifier.otherdoi:10.1371/journal.pmed.1001067
dc.identifier.urihttp://hdl.handle.net/10019.1/17092
dc.publisherPublic Library of Science
dc.rights.holderAuthors retain copyright
dc.subjectTuberculosisen_ZA
dc.subjectHIV infectionsen_ZA
dc.subjectAntiretroviral agentsen_ZA
dc.titleScreening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay : a prospective studyen_ZA
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
lawn_screening_2011.PDF
Size:
225.03 KB
Format:
Adobe Portable Document Format
Description:
Download article
Download
Collections
Research Articles ((SACEMA) South African Centre for Epidemiological Modelling and Analysis )